Determinants of Deescalation Failure in Critically Ill Patients with Sepsis: A Prospective Cohort Study
Introduction. Deescalation refers to either discontinuation or a step-down of antimicrobials. Despite strong recommendations in the Surviving Sepsis Guidelines (2012) to deescalate, actual practices can vary. Our objective was to identify variables that are associated with deescalation failure. Meth...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Critical Care Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2016/6794861 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832564192288178176 |
---|---|
author | Nawal Salahuddin Lama Amer Mini Joseph Alya El Hazmi Hassan Hawa Khalid Maghrabi |
author_facet | Nawal Salahuddin Lama Amer Mini Joseph Alya El Hazmi Hassan Hawa Khalid Maghrabi |
author_sort | Nawal Salahuddin |
collection | DOAJ |
description | Introduction. Deescalation refers to either discontinuation or a step-down of antimicrobials. Despite strong recommendations in the Surviving Sepsis Guidelines (2012) to deescalate, actual practices can vary. Our objective was to identify variables that are associated with deescalation failure. Methods. In this prospective study of patients with sepsis/septic shock, patients were categorized into 4 groups based on antibiotic administration: no change in antibiotics, deescalation, escalation (where antibiotics were changed to those with a broader spectrum of antimicrobial coverage), or mixed changes (where both escalation to a broader spectrum of coverage and discontinuation of antibiotics were carried out). Results. 395 patients were studied; mean APACHE II score was 24±7.8. Antimicrobial deescalation occurred in 189 (48%) patients; no changes were made in 156 (39%) patients. On multivariate regression analysis, failure to deescalate was significantly predicted by hematologic malignancy OR 3.3 (95% CI 1.4–7.4) p<0.004, fungal sepsis OR 2.7 (95% CI 1.2–5.8) p=0.011, multidrug resistance OR 2.9 (95% CI 1.4–6.0) p=0.003, baseline serum procalcitonin OR 1.01 (95% CI 1.003–1.016) p=0.002, and SAPS II scores OR 1.01 (95% CI 1.004–1.02) p=0.006. Conclusions. Current deescalation practices reflect physician reluctance when dealing with complicated, sicker patients or with drug-resistance or fungal sepsis. Integrating an antibiotic stewardship program may increase physician confidence and provide support towards increasing deescalation rates. |
format | Article |
id | doaj-art-515117443334436ca30a54d36cf9df8a |
institution | Kabale University |
issn | 2090-1305 2090-1313 |
language | English |
publishDate | 2016-01-01 |
publisher | Wiley |
record_format | Article |
series | Critical Care Research and Practice |
spelling | doaj-art-515117443334436ca30a54d36cf9df8a2025-02-03T01:11:36ZengWileyCritical Care Research and Practice2090-13052090-13132016-01-01201610.1155/2016/67948616794861Determinants of Deescalation Failure in Critically Ill Patients with Sepsis: A Prospective Cohort StudyNawal Salahuddin0Lama Amer1Mini Joseph2Alya El Hazmi3Hassan Hawa4Khalid Maghrabi5King Faisal Specialist Hospital & Research Center, Riyadh 11211, Saudi ArabiaDepartment of Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh 11211, Saudi ArabiaDepartment of Nursing, King Faisal Specialist Hospital & Research Centre, Riyadh 11211, Saudi ArabiaAdult Critical Care Medicine, King Faisal Specialist Hospital & Research Center, Riyadh 11211, Saudi ArabiaAdult Critical Care Medicine, King Faisal Specialist Hospital & Research Center, Riyadh 11211, Saudi ArabiaKing Faisal Specialist Hospital & Research Center, Riyadh 11211, Saudi ArabiaIntroduction. Deescalation refers to either discontinuation or a step-down of antimicrobials. Despite strong recommendations in the Surviving Sepsis Guidelines (2012) to deescalate, actual practices can vary. Our objective was to identify variables that are associated with deescalation failure. Methods. In this prospective study of patients with sepsis/septic shock, patients were categorized into 4 groups based on antibiotic administration: no change in antibiotics, deescalation, escalation (where antibiotics were changed to those with a broader spectrum of antimicrobial coverage), or mixed changes (where both escalation to a broader spectrum of coverage and discontinuation of antibiotics were carried out). Results. 395 patients were studied; mean APACHE II score was 24±7.8. Antimicrobial deescalation occurred in 189 (48%) patients; no changes were made in 156 (39%) patients. On multivariate regression analysis, failure to deescalate was significantly predicted by hematologic malignancy OR 3.3 (95% CI 1.4–7.4) p<0.004, fungal sepsis OR 2.7 (95% CI 1.2–5.8) p=0.011, multidrug resistance OR 2.9 (95% CI 1.4–6.0) p=0.003, baseline serum procalcitonin OR 1.01 (95% CI 1.003–1.016) p=0.002, and SAPS II scores OR 1.01 (95% CI 1.004–1.02) p=0.006. Conclusions. Current deescalation practices reflect physician reluctance when dealing with complicated, sicker patients or with drug-resistance or fungal sepsis. Integrating an antibiotic stewardship program may increase physician confidence and provide support towards increasing deescalation rates.http://dx.doi.org/10.1155/2016/6794861 |
spellingShingle | Nawal Salahuddin Lama Amer Mini Joseph Alya El Hazmi Hassan Hawa Khalid Maghrabi Determinants of Deescalation Failure in Critically Ill Patients with Sepsis: A Prospective Cohort Study Critical Care Research and Practice |
title | Determinants of Deescalation Failure in Critically Ill Patients with Sepsis: A Prospective Cohort Study |
title_full | Determinants of Deescalation Failure in Critically Ill Patients with Sepsis: A Prospective Cohort Study |
title_fullStr | Determinants of Deescalation Failure in Critically Ill Patients with Sepsis: A Prospective Cohort Study |
title_full_unstemmed | Determinants of Deescalation Failure in Critically Ill Patients with Sepsis: A Prospective Cohort Study |
title_short | Determinants of Deescalation Failure in Critically Ill Patients with Sepsis: A Prospective Cohort Study |
title_sort | determinants of deescalation failure in critically ill patients with sepsis a prospective cohort study |
url | http://dx.doi.org/10.1155/2016/6794861 |
work_keys_str_mv | AT nawalsalahuddin determinantsofdeescalationfailureincriticallyillpatientswithsepsisaprospectivecohortstudy AT lamaamer determinantsofdeescalationfailureincriticallyillpatientswithsepsisaprospectivecohortstudy AT minijoseph determinantsofdeescalationfailureincriticallyillpatientswithsepsisaprospectivecohortstudy AT alyaelhazmi determinantsofdeescalationfailureincriticallyillpatientswithsepsisaprospectivecohortstudy AT hassanhawa determinantsofdeescalationfailureincriticallyillpatientswithsepsisaprospectivecohortstudy AT khalidmaghrabi determinantsofdeescalationfailureincriticallyillpatientswithsepsisaprospectivecohortstudy |